Specify a stock or a cryptocurrency in the search bar to get a summary
Liaoning Chengda Biotechnology Co. Ltd. A
688739Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China. It offers Chengda Suda human rabies and Chengda Libao Human Type B inactivated encephalitis vaccines. The company also exports its products to 32 countries including India, Pakistan, Thailand, the Philippines, Kenya, Ghana, Malawi, Georgia, and other countries. Liaoning Chengda Biotechnology Co.,Ltd. was founded in 2002 and is headquartered in Shenyang, China. Address: No. 1 Xinfang Street, Shenyang, China, 110179
Analytics
WallStreet Target Price
289.3 CNYP/E ratio
34.7531Dividend Yield
2.96 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688739
Dividend Analytics 688739
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
74 %Dividend History 688739
Stock Valuation 688739
Financials 688739
Results | 2019 | Dynamics |